Den Europæiske Union - slovakisk - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - radionuklidové zobrazovanie - terapeutické rádiofarmaká - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Den Europæiske Union - slovakisk - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidové zobrazovanie - diagnostické rádiofarmaká - tento liek je určený len na diagnostické účely. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Slovakiet - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovakiet - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovakiet - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)